Streetbeat News

Price Targets

GHRS

JMP Securities has reiterated a Market Outperform rating for GH Research (NASDAQ:GHRS) and maintained a price target of $39.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:21 pm

CYTK

JMP Securities analyst Jason Butler has reiterated a Market Outperform rating for Cytokinetics (NASDAQ:CYTK) and maintained a price target of $78.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:18 pm

FBLG

EF Hutton has initiated coverage on FibroBiologics with a Buy rating and set a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:17 pm

SRAD

JMP Securities has upgraded Sportradar Gr (NASDAQ:SRAD) from Market Perform to Market Outperform, setting a price target of $16.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:16 pm

ZS

Zscaler Inc (NASDAQ:ZS) reported strong fiscal Q4 results, but its shares fell due to concerns over its fiscal 2025 guidance. Despite beating revenue and billings expectations, analysts cut price targets citing incremental risks and back-end loaded billings guidance.

Portfolio Pulse from Priya Nigam

September 04, 2024 | 4:12 pm

ASAN

JMP Securities has maintained a Market Outperform rating on Asana but lowered its price target from $27 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:10 pm

NOK

Northland Capital Markets has reiterated an Outperform rating on Nokia and raised its price target from $6 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:08 pm

BLRX

Jones Trading has initiated coverage on BioLine Rx with a Buy rating and set a price target of $2. This suggests a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:06 pm

CORZ

Core Scientific shares rose after Needham initiated coverage with a Buy rating and a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:05 pm

AVDX

Compass Point has initiated coverage on AvidXchange Holdings with a Neutral rating and set a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 4:01 pm